Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,399 | 754 | 99.8% |
| Education | $17.19 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,307 | 65 | $0 (2024) |
| ABBVIE INC. | $1,059 | 65 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $821.76 | 46 | $0 (2024) |
| Novo Nordisk Inc | $748.29 | 62 | $0 (2024) |
| Lilly USA, LLC | $628.02 | 51 | $0 (2024) |
| Amgen Inc. | $609.58 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $596.69 | 44 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $584.33 | 39 | $0 (2024) |
| PFIZER INC. | $559.76 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $535.47 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,602 | 94 | ABBVIE INC. ($343.53) |
| 2023 | $1,396 | 92 | ABBVIE INC. ($239.21) |
| 2022 | $1,506 | 91 | Novartis Pharmaceuticals Corporation ($295.23) |
| 2021 | $1,488 | 88 | AbbVie Inc. ($224.84) |
| 2020 | $1,446 | 93 | AstraZeneca Pharmaceuticals LP ($212.78) |
| 2019 | $1,163 | 85 | AstraZeneca Pharmaceuticals LP ($142.62) |
| 2018 | $1,402 | 106 | AstraZeneca Pharmaceuticals LP ($247.30) |
| 2017 | $1,412 | 109 | AstraZeneca Pharmaceuticals LP ($208.12) |
All Payment Transactions
758 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $45.95 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $7.29 | General |
| Category: Neurology | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 6,707 | 9,384 | $689,664 | $394,042 |
| 2022 | 44 | 6,543 | 9,106 | $670,171 | $378,193 |
| 2021 | 31 | 6,903 | 9,539 | $704,764 | $411,104 |
| 2020 | 37 | 6,976 | 9,924 | $731,838 | $382,191 |
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 900 | 1,616 | $274,630 | $133,504 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 675 | 675 | $101,250 | $84,665 | 83.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 504 | 794 | $87,290 | $46,146 | 52.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 134 | 144 | $25,920 | $19,974 | 77.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 75 | 88 | $28,600 | $18,530 | 64.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 171 | 171 | $12,825 | $12,300 | 95.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 803 | 1,429 | $14,290 | $12,004 | 84.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 630 | 630 | $15,750 | $11,158 | 70.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 599 | 633 | $18,990 | $8,281 | 43.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 583 | 796 | $15,915 | $7,559 | 47.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 610 | 712 | $28,448 | $7,346 | 25.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 182 | 182 | $5,460 | $5,463 | 100.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,700 | $5,365 | 94.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 30 | $6,750 | $4,602 | 68.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 24 | 74 | $6,290 | $3,358 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $7,920 | $2,882 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 240 | $9,600 | $2,236 | 23.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 37 | 45 | $4,635 | $1,814 | 39.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 16 | $1,760 | $1,079 | 61.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 42 | 67 | $2,144 | $953.57 | 44.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 27 | 31 | $2,480 | $884.40 | 35.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $570.00 | $570.38 | 100.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 19 | 129 | $903.00 | $541.80 | 60.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 134 | 240 | $2,880 | $525.80 | 18.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $660.00 | $390.28 | 59.1% |
About Dr. Joshua Frame, DO
Dr. Joshua Frame, DO is a Internal Medicine healthcare provider based in St George, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437143443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Frame, DO has received a total of $11,416 in payments from pharmaceutical and medical device companies, with $1,602 received in 2024. These payments were reported across 758 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($11,399).
As a Medicare-enrolled provider, Frame has provided services to 27,129 Medicare beneficiaries, totaling 37,953 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location St George, UT
- Active Since 09/06/2005
- Last Updated 12/19/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437143443
Products in Payments
- FARXIGA (Drug) $903.20
- VRAYLAR (Drug) $515.97
- LEQVIO (Drug) $426.27
- ENTRESTO (Drug) $395.49
- Trintellix (Drug) $373.95
- XARELTO (Drug) $370.08
- UBRELVY (Drug) $348.71
- JARDIANCE (Drug) $313.53
- Ozempic (Drug) $305.86
- TOUJEO (Drug) $295.99
- NURTEC ODT (Drug) $287.16
- ZENPEP (Drug) $279.65
- BREZTRI (Drug) $241.64
- MOUNJARO (Drug) $225.68
- TRADJENTA (Drug) $191.67
- Aimovig (Biological) $185.48
- QULIPTA (Drug) $177.80
- INVOKANA (Drug) $165.39
- CHANTIX (Drug) $159.79
- TRULICITY (Drug) $140.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in St George
Dr. Blake Gardner, Md, MD
Internal Medicine — Payments: $299,885
Weston Harkness, D.o, D.O
Internal Medicine — Payments: $43,038
Dr. John Erikson Yap, M.d, M.D
Internal Medicine — Payments: $35,600
Jared Crisafi, M.d, M.D
Internal Medicine — Payments: $22,496
Jeff Jensen
Internal Medicine — Payments: $7,246
John Powell, Pa C, PA C
Internal Medicine — Payments: $5,873